IQ-AI Ltd. is a holding company, which engages in the provision of clinical treatments to patients in the field of medical imaging diagnostics. It accelerates the translation and commercialization of proven imaging technologies, from the laboratory to routine clinical use, that have potential to dramatically impact the quality of life for patients facing brain tumours and other chronic diseases. It operates through the Holding Company and Medical Software segments. The company was founded in 1965 and is headquartered in St. Helier, the United Kingdom.